Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

White House Blasts ‘Unserious Gossip Columnist’ For ‘Baseless Speculation’ About President Trump’s Health: ‘Good Job, Loser’


When it comes to denigrating President Donald Trump and his achievements in office, there seems to be no wild conspiracy that his leftist critics won’t believe.

And some of those people happen to work in the mainstream media.

One apparent example involves unsubstantiated rumors that the president had been given “compassionate use” access to Eli Lilly’s retatrutide drug, which is billed to aid in weight loss but has not yet been FDA approved.

The Hill provided details of the exchange between the White House and reporters:

ADVERTISEMENT

Three anonymous sources familiar with the matter told STAT News, the patient approved to receive retatrutide was 79 years old, leading the outlet to believe the prescription could have been issued to Trump who turned 80 last week. 

“Because this has to be spelled out for @LizzyLaw, who has proven herself to be an unserious gossip columnist, this application was not for the President,” White House senior deputy press secretary Kush Desai wrote in a Tuesday post on X, referring to reporter Lizzy Lawrence who authored the article. 

Lawrence said the White House and Department of Health and Human Services did not respond to multiple inquiries asking if the president was using the obesity drug. 

“We shouldn’t have to bat down baseless speculation for you to not print it. Any reporter with standards would understand this,” Desai wrote in response to her post.

“Are you going to now go ask this idiotic question to the ~4 million Americans in this age cohort and then speculate about them being the application?” he added. 

Trump weighs 224 pounds according to a physical from last year and has previously shared that he “probably” should be on weight loss drugs when asked about whether he’d been prescribed GLP-1 drugs in an interview with The New York Times. 

When Lawrence followed up on X, outspoken White House communications director Steven Cheung took another shot at her:

Here’s some of the reaction to Desai’s post:

ADVERTISEMENT

 

 

Of course, all those denials weren’t enough to convince the die-hard Trump haters.

Here’s how far-left Mother Jones ended its report on the same topic:

But perhaps the biggest tell is the president’s unflinching record of indifference when it comes to outcries over inappropriate behavior, general shadiness, and conflicts of interest. So did Trump use the levers of power to gain unusual access to retatrutide? Time will tell if the president starts to debut a trimmed-down physique. It’s either that or the kimchi.

Here’s some additional coverage:

ADVERTISEMENT

What are your thoughts?

NATIONAL POLL: Do You Still TRUST President Trump? vote now

TAP HERE TO ADD YOUR VOTE



 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Leave a comment
Thanks for sharing!